Show simple item record

dc.contributor.authorDuan, Xiaowen
dc.contributor.authorNorris, Dougall M
dc.contributor.authorHumphrey, Sean J
dc.contributor.authorYang, Pengyi
dc.contributor.authorCooke, Kristen C
dc.contributor.authorBultitude, Will P
dc.contributor.authorParker, Benjamin L
dc.contributor.authorConway, Olivia J
dc.contributor.authorBurchfield, James G
dc.contributor.authorKrycer, James R
dc.contributor.authorBrodsky, Frances M
dc.contributor.authorJames, David E
dc.contributor.authorFazakerley, Daniel J
dc.date.accessioned2022-05-24T23:30:12Z
dc.date.available2022-05-24T23:30:12Z
dc.date.issued2022-06-17
dc.identifier.issn0264-6021
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/337437
dc.description.abstractTrafficking regulator of GLUT4-1, TRARG1, positively regulates insulin-stimulated GLUT4 trafficking and insulin sensitivity. However, the mechanism(s) by which this occurs remain(s) unclear. Using biochemical and mass spectrometry analyses we found that TRARG1 is dephosphorylated in response to insulin in a PI3K/Akt-dependent manner and is a novel substrate for GSK3. Priming phosphorylation of murine TRARG1 at serine 84 allows for GSK3-directed phosphorylation at serines 72, 76 and 80. A similar pattern of phosphorylation was observed in human TRARG1, suggesting that our findings are translatable to human TRARG1. Pharmacological inhibition of GSK3 increased cell surface GLUT4 in cells stimulated with a submaximal insulin dose, and this was impaired following Trarg1 knockdown, suggesting that TRARG1 acts as a GSK3-mediated regulator in GLUT4 trafficking. These data place TRARG1 within the insulin signaling network and provide insights into how GSK3 regulates GLUT4 trafficking in adipocytes.
dc.publisherPortland Press Ltd.
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleTrafficking regulator of GLUT4-1 (TRARG1) is a GSK3 substrate.
dc.typeArticle
dc.publisher.departmentDepartment of Clinical Biochemistry
dc.date.updated2022-05-23T12:07:24Z
prism.publicationNameBiochem J
dc.identifier.doi10.17863/CAM.84850
dcterms.dateAccepted2022-05-20
rioxxterms.versionofrecord10.1042/BCJ20220153
rioxxterms.versionVoR
dc.contributor.orcidFazakerley, Daniel J [0000-0001-8241-2903]
dc.identifier.eissn1470-8728
rioxxterms.typeJournal Article/Review
pubs.funder-project-idMedical Research Council (MR/S007091/1)
pubs.funder-project-idWellcome Trust (208363/Z/17/Z)
cam.issuedOnline2022-06-13
cam.orpheus.success2022/06/01
cam.orpheus.counter1
cam.depositDate2022-05-23
pubs.licence-identifierapollo-deposit-licence-2-1
pubs.licence-display-nameApollo Repository Deposit Licence Agreement


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International